The French pharma is handing over $125 million upfront, with a near-term payment of $50 million to follow, for the exclusive worldwide rights to a pair of bispecific antibodies. HXN-1002 targets ...

BigHat Biosciences, a Californian biotech with a machine learning (ML)-guided antibody discovery and development platform, has announced a strategic collaboration with US pharma major Eli Lilly (NYSE: ...

Introduction: Antibody maturation in the lymphoid follicle produces antibodies with improved binding affinity. This process requires iterative rounds of mutation and B cell expansion, supported by T ...

Antibody-based therapies such as antibody-drug conjugates and T-cell engagers continue to show great potential in the treatment of solid tumors. So far, six ADCs and two TCEs are FDA-approved for ...

NANJING, China, April 15, 2025 /PRNewswire/ -- ProBio, a global leader in the antibody discovery and development, is pleased to announce its upcoming poster presentation at the American Association ...

In a significant move toward modernizing drug development, the U.S. Food and Drug Administration (USFDA) has announced plans to phase out its long-standing requirement for animal testing in the ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that ...

The FDA said it plans to phase out animal testing requirements for monoclonal antibodies and other drugs, replacing them with “more effective, human-relevant methods.” Shares in Charles River ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer. Research has shed light on how a new type of antibody treatment ...